Retatrutide creates a window of opportunity for fat loss, not a permanent solution
Johnson AP, Vu TT, Simon J, Ryan GL
Moreover, the regulatory frameworks for innovative multi-target therapies are complex, necessitating extensive safety databases including varied patient demographics
A short course is often practical, and long-term use may require a lower maintenance dose with tapering under medical supervision
If the short BUD creates logistical problems for your protocol, asking the pharmacy about their stability testing or comparing with other providers is reasonable
Clinical research provides more reliable context than an isolated image or social-media claim